Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships

University of Toronto

$105,000.00

The Role of Astrocytes in the Regulation of Multidrug Resistance at the Developing Blood-Brain Barrier

EF 2014-15

Résumé
Drug treatment targeted at relieving brain disorders has proven to be a rather difficult task. The few pharmaceuticals that are able to cross the barrier between the blood and the brain ('blood brain barrier' (bbb)) are often pumped out of the brain by proteins known as 'multidrug resistance transporters'. These drug transporters keep out a wide range of compounds, which include a number of toxins, but also chemotherapeutics and natural compounds produced in the body. The role of these transporters is dual: to protect the brain and regulate what gets in and what gets out. However, in early fetal development, these drug transporters are not fully expressed at the bbb, which leaves the developing fetus susceptible to harmful compounds that could possibly enter from maternal circulation. Our lab have shown that the levels of these drug transporters dramatically increases at the bbb in late gestation and post-natal life, correlating with the period of rapid brain growth in the fetus - a time when the brain is most vulnerable to teratogens. This period of rapid brain growth is attributed to rapidly developing 'astrocytes', a vital cell in the brain. We hypothesize that 'astrocytes' regulate brain protection in the developing bbb. Astrocytes play a key role in neurodevelopmental disorders, such as Retts Syndrome and Fragile X mental retardation. Altered development of astrocytes observed in these disorders, may effect brain protection during fetal development and thus aid in disease progression. Our research will provide insight into how drug transporters at the bbb are regulated and investigate a possible link between altered brain protection and neurodevelopmental diseases. We can then improve clinical strategies focused on preventing neurodevelopmental disorders and congenital defects. Furthermore, a better understanding of how the bbb develops will contribute greatly to current knowledge in brain disorder research (i.e. cancer, stroke, etc.).
Programme
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
327838
Name
Baello Stephanie
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Human Development, Child and Youth Health
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
The Role of Astrocytes in the Regulation of Multidrug Resistance at the Developing Blood-Brain Barrier
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Astrocytes; Blood-Brain Barrier; Brain Endothelial Cells; Co-Culture; Development; Fetus; Multidrug Resistance; P-Glycoprotein
Abstract
Drug treatment targeted at relieving brain disorders has proven to be a rather difficult task. The few pharmaceuticals that are able to cross the barrier between the blood and the brain ('blood brain barrier' (bbb)) are often pumped out of the brain by proteins known as 'multidrug resistance transporters'. These drug transporters keep out a wide range of compounds, which include a number of toxins, but also chemotherapeutics and natural compounds produced in the body. The role of these transporters is dual: to protect the brain and regulate what gets in and what gets out. However, in early fetal development, these drug transporters are not fully expressed at the bbb, which leaves the developing fetus susceptible to harmful compounds that could possibly enter from maternal circulation. Our lab have shown that the levels of these drug transporters dramatically increases at the bbb in late gestation and post-natal life, correlating with the period of rapid brain growth in the fetus - a time when the brain is most vulnerable to teratogens. This period of rapid brain growth is attributed to rapidly developing 'astrocytes', a vital cell in the brain. We hypothesize that 'astrocytes' regulate brain protection in the developing bbb. Astrocytes play a key role in neurodevelopmental disorders, such as Retts Syndrome and Fragile X mental retardation. Altered development of astrocytes observed in these disorders, may effect brain protection during fetal development and thus aid in disease progression. Our research will provide insight into how drug transporters at the bbb are regulated and investigate a possible link between altered brain protection and neurodevelopmental diseases. We can then improve clinical strategies focused on preventing neurodevelopmental disorders and congenital defects. Furthermore, a better understanding of how the bbb develops will contribute greatly to current knowledge in brain disorder research (i.e. cancer, stroke, etc.).
Competitiondate
201410
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Baello, Stephanie
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~